Spotlight on Triptorelin in the Treatment of Premenopausal Women with Early-Stage Breast Cancer
[Breast Cancer: Targets and Therapy] Researchers present a review of the LHRH agonist triptorelin and the use of this agent to induce chemical castration in estrogen-sensitive breast cancer tumors in younger women.
